Nature Medicine, Published online: 27 May 2025; doi:10.1038/s41591-025-03715-6
In the Tumor Profiler proof-of-concept observational study, a multiomics approach for profiling tumors from patients with melanoma was feasible, returning data within 4 weeks and informing treatment recommendations in 75% of cases.
